News & Updates

Show Multimedia Only

High-dose oxytocin does not cut Caesarean delivery rates vs standard dosing

23 Feb 2021 by

Using high-dose oxytocin for labour augmentation did not significantly reduce the incidence of Caesarean delivery among nulliparous women compared with standard dosing, according to a study presented at SMFM 2021.

High-dose oxytocin does not cut Caesarean delivery rates vs standard dosing

23 Feb 2021

Dexamethasone lowers mortality, ventilation use in ARDS

22 Feb 2021 by

Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.

Dexamethasone lowers mortality, ventilation use in ARDS

22 Feb 2021

CI hydrocortisone for septic shock shows no positive impact on glycaemic control

22 Feb 2021

Continuous infusion (CI) hydrocortisone therapy in patients with septic shock is not associated with a beneficial impact on mean blood glucose or influence glycaemic variability as compared to bolus dose (BD) therapy, reports a study.

CI hydrocortisone for septic shock shows no positive impact on glycaemic control

22 Feb 2021

Naltrexone-bupropion shows promise for meth withdrawal

22 Feb 2021 by

In individuals with moderate or severe methamphetamine use disorder (MUD), a combination of naltrexone and bupropion (NB) appeared to be more effective than placebo in facilitating methamphetamine (meth) withdrawal, results of the ADAPT-2* trial suggest.

Naltrexone-bupropion shows promise for meth withdrawal

22 Feb 2021

Systemic corticoids cut death risk in critically ill COVID-19 patients

22 Feb 2021 by

The systemic use of corticosteroids lowers 28-day all-cause mortality among patients with the novel coronavirus disease (COVID-19), as opposed to usual care or placebo, according to the REACT* meta-analysis presented at the recently concluded eCritical Care Reviews Meeting 2021 (eCCR21).

Systemic corticoids cut death risk in critically ill COVID-19 patients

22 Feb 2021

Long-term prediagnostic aspirin use yields survival benefit in CRC

22 Feb 2021

Among patients with nonmetastatic colorectal cancer (CRC), long-term use of aspirin prior to diagnosis appears to cut the risk of CRC-specific mortality, a study has found.

Long-term prediagnostic aspirin use yields survival benefit in CRC

22 Feb 2021

Second-line avelumab shows therapeutic potential in advanced HCC

21 Feb 2021

Use of the antiprogrammed death ligand 1 (PD-L1) antibody avelumab in the second-line treatment of patients with advanced hepatocellular carcinoma (HCC) yields moderate efficacy with tolerable safety profile, according to the results of a phase II trial.

Second-line avelumab shows therapeutic potential in advanced HCC

21 Feb 2021

Two-bag on par with one-bag system in adults with diabetic ketoacidosis

21 Feb 2021

The efficacy and safety of the two-bag (TB) system are comparable to those of the one-bag (OB) system in adults with diabetic ketoacidosis (DKA), results of a study have shown. Both approaches can be considered in adult DKA patients.

Two-bag on par with one-bag system in adults with diabetic ketoacidosis

21 Feb 2021

Roflumilast does not ease arterial stiffness in COPD patients

20 Feb 2021

Treatment with the phosphodiesterase 4 inhibitor roflumilast does not appear to provide any benefits on arterial stiffness in patients with chronic obstructive pulmonary disease (COPD), suggest the results of a study.

Roflumilast does not ease arterial stiffness in COPD patients

20 Feb 2021

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

19 Feb 2021 by

Among critically ill adults receiving mechanical ventilation in the intensive care unit (ICU), a protocol of no sedation is comparable to light sedation with daily interruption in terms of mortality, as shown in the NONSEDA trial.

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

19 Feb 2021

News & Updates

Filter by Specialty:

Specialty:

High-dose oxytocin does not cut Caesarean delivery rates vs standard dosing

High-dose oxytocin does not cut Caesarean delivery rates vs standard dosing

Dexamethasone lowers mortality, ventilation use in ARDS

Dexamethasone lowers mortality, ventilation use in ARDS

CI hydrocortisone for septic shock shows no positive impact on glycaemic control

CI hydrocortisone for septic shock shows no positive impact on glycaemic control

Naltrexone-bupropion shows promise for meth withdrawal

Naltrexone-bupropion shows promise for meth withdrawal

Systemic corticoids cut death risk in critically ill COVID-19 patients

Systemic corticoids cut death risk in critically ill COVID-19 patients

Long-term prediagnostic aspirin use yields survival benefit in CRC

Long-term prediagnostic aspirin use yields survival benefit in CRC

Second-line avelumab shows therapeutic potential in advanced HCC

Second-line avelumab shows therapeutic potential in advanced HCC

Two-bag on par with one-bag system in adults with diabetic ketoacidosis

Two-bag on par with one-bag system in adults with diabetic ketoacidosis

Roflumilast does not ease arterial stiffness in COPD patients

Roflumilast does not ease arterial stiffness in COPD patients

NONSEDA: Some mechanically ventilated ICU patients need not be sedated

NONSEDA: Some mechanically ventilated ICU patients need not be sedated